Chronic Obstructive Pulmonary Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-10-28

Study Completion Date

2017-06-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic Obstructive Pulmonary Disease (COPD) is a preventable respiratory characterized by airflow obstruction that is not fully reversible. This disease a major cause of mortality worldwide. It is projected to rank the third-leading cause of death in 2020.

The objective of this study is to examine the effects of a physical therapy intervention in stable patients with COPD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Neuromuscular Electrical Stimulation in Chronic Obstructive Pulmonary Disease (COPD)

NCT00677690

Chronic Obstructive Pulmonary Disease

COMPLETED PHASE3

Exercise Training and Inflammatory Mediators in COPD

NCT03853174

COPD

COMPLETED NA

Chronic Obstructive Pulmonary Diseases and Proprioceptive Neuromuscular Facilitation

NCT05723302

Chronic Obstructive Pulmonary Disease

COMPLETED NA

Physiotherapy in Patients With Stable Chronic Obstructive Pulmonary Disease

NCT02517411

COPD

COMPLETED NA

The Effect of a Respiratory Muscle Warm-up Prior to Exercise in Patients With Chronic Obstructive Pulmonary Disease

NCT02532075

Chronic Obstructive Pulmonary Disease

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic obstructive pulmonary disease (COPD) patients have demonstrated important balance impairment (1).The deficit in balance control is identified as one of the risk factors of fall in subjects with COPD and alters their activities daily life (2,3). Porto and al. (2015) reported in a recent review that individuals with COPD have a decline in balance control when compared with healthy age matched controls(4).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Differents groups received differents training protocoles during the same duration

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ET+RT+ NMES

neuromuscular electrical training NMES

Group Type ACTIVE_COMPARATOR

ET+RT+ NMES

Intervention Type OTHER

Endurance training, resistance training and neuromuscular electrical stimuation were prformed. Intensity was gradually increased.

ET+RT

placebo neuromuscular electrical training NMES

Group Type PLACEBO_COMPARATOR

ET+RT+ NMES

Intervention Type OTHER

Endurance training, resistance training and neuromuscular electrical stimuation were prformed. Intensity was gradually increased.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ET+RT+ NMES

Endurance training, resistance training and neuromuscular electrical stimuation were prformed. Intensity was gradually increased.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* COPD diagnosed by pulmonary function testing
* Clinically stable
* Abscence of other obstructive diseases
* Signed written consent
* Fall in the past five years or recent near fall

Exclusion Criteria

* Neuromuscular diseases
* Severe psychiatric, neurologic or musculoskeletal conditions and /or instable cardiovascular diseases.
* Contre-indications to physical therapy
* Acute exacerbations a month before the intervention

Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No